With the continuous favorable policies in the field of traditional Chinese medicine, how should pharmaceutical companies seize the opportunity?

In 2021, heavy support policies for the traditional Chinese medicine industry will be issued frequently
.
For example, on July 1 last year, relevant departments issued the "14th Five-Year Plan for the Construction of High-quality and Efficient Medical and Health Service System Construction Implementation Plan", which clearly proposed to promote the inheritance and innovation of traditional Chinese medicine, while focusing on supporting the National Center for Traditional Chinese Medicine, the National Center for Chinese Medicine The construction of the Medicine Inheritance and Innovation Center and the National TCM Disease Prevention and Control Base
.
The industry believes that this means that the development of the traditional Chinese medicine industry will become the top priority in the period from 2021 to 2025
.
Subsequently, on December 30, the National Medical Security Administration and the State Administration of Traditional Chinese Medicine jointly issued the "Guiding Opinions on Medical Insurance Supporting the Inheritance and Innovation of Traditional Chinese Medicine", clarifying that general TCM medical services can continue to be paid by the project, and TCM medical institutions can For the time being, the payment by disease diagnosis-related group (DRG) is not implemented.
For areas that have implemented DRG and payment by disease score, appropriately increase the coefficient and score of TCM medical institutions and TCM diseases.
.
.
In this regard, the industry generally believes that, Under the influence of a series of favorable policies, the development of the traditional Chinese medicine industry will continue to accelerate
.
However, it should be noted that there are still bottlenecks in the development of China's traditional Chinese medicine industry, such as focusing on sales and ignoring R&D, weak overall competitiveness, and insufficient innovation vitality of enterprises
.
In this context, how should pharmaceutical companies seize the opportunity? Some people in the industry pointed out that in order to seize the opportunity, traditional Chinese medicine enterprises need to grasp both the soft and the hard
.
First of all, the quality and innovation must be continuously improved; in addition, the publicity and promotion of traditional Chinese medicine must also be strengthened
.
For a long time, in the production of traditional Chinese medicine, ensuring the quality of medicines is very important
.
Therefore, if pharmaceutical companies want to better promote the development of traditional Chinese medicine, they must better ensure the safety of drugs
.
In this context, pharmaceutical companies can continuously promote the high-quality development of the Chinese medicine industry through technological innovation, the development of modern Chinese medicine scientific research and industrial production technology
.
It is reported that at present, some enterprises have carried out dosage form reform while inheriting traditional Chinese medicine decoction, digitally characterizing traditional experience, and concocting through modern industrial equipment.
convenient for patients to take
.
In the promotion of traditional Chinese medicine, relevant enterprises can promote the globalization of traditional Chinese medicine by cultivating comprehensive talents
.
The analysis believes that the "going out" of traditional Chinese medicine covers many industries such as medical treatment, education, culture, industry, equipment, and services.
It is necessary to build compound industrial talents in order to lay a solid foundation for the overseas development of the traditional Chinese medicine industry
.
In this context, pharmaceutical companies need more time and use various ways to cultivate professional and comprehensive industrial talents to provide talent support for the promotion of traditional Chinese medicine
.
In general, with the help of policies, the pace of development of traditional Chinese medicine will be further accelerated in the future, and the market size will also show a trend of steady growth
.
At the same time, a large number of related companies are expected to usher in a larger market development space and move towards a higher-quality development path through continuous inheritance of essence, integrity and innovation
.